Senior Manager, Payer and Channel Marketing
Posted on: 9 Jan 2021
Weston, MA
Job Description
Job Description
The Senior Manager, Payer and Channel Marketing will design and support the development of key initiatives and tactics for payer channels which include:
* Private and government payers
* PBMs
* Specialty Pharmacy and Distributors
* Hospitals, Treatment Centers, and Providers
Essential functions of the job include:
Leading implementation of key tactics that support broad access and reimbursement strategy for MS products
Serving as a key subject matter expert and source of market-specific information, segmentation, strategic direction, and tactical concepts
Aligning with brand teams to develop messaging to drive value to government and private payers and channel customers
Determining appropriate marketing mix to drive product access and refine mix based on customer and market feedback
Gathering data, design customer development programs, and lead the development of strategies and tactics in collaboration with brand product managers and field teams
Acting as a liaison with cross functional partners to lead and guide tactic and program development
Managing the regulatory and legal approval process for market access tactics and deliverables
Developing the annual brand plan from a Market Access and Reimbursement perspective, while ensuring alignment with the US brand and global teams
* LI-SR6
Qualifications
5-7 years pharmaceutical or biotechnology experience, including payer marketing, marketing, sales, health economics, and account management-related activities
Understanding of health care delivery and payment/insurance systems in the US
Advanced business and financial acumen skills with the ability to apply them productively in lateral and superior relationships; detailed oriented, strong quantitative and analytical ability
Proven ability to use customer and marketplace insights to identify, develop and implement initiatives that meet customer and company needs
Experience managing key commercial processes that are critical to business performance, including brand planning and positioning, value proposition development, pricing and reimbursement strategy, and life cycle management
Excellent communication skills, presentation skills and the ability to work effectively with cross-functional teams
Strong analytical, problem solving and strategic thinking skills
Ability to work under pressure and multi-task
Ability to navigate and be successful in a fast-paced, dynamic environment
Education: Bachelor's degree required; advanced education/degree preferred
Additional Information
The Senior Manager, Payer and Channel Marketing will design and support the development of key initiatives and tactics for payer channels.
Biogen
Cambridge, MA
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis (MS); SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; FLIXABI, an infliximab biosimilar referencing REMICADE; and IMRALDI, an adalimumab biosimilar referencing HUMIRA. In addition, the company offers RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for the treatment of primary progressive MS and relapsing MS, and other anti-CD20 therapies.
Further, it is involved in developing BIIB098, Opicinumab, and BIIB061 for MS and neuroimmunology; Aducanumab, Elenbecestat, BAN2401, BIIB092, BIIB076, and BIIB080 to treat Alzheimer's disease and dementia; BIIB092 and BIIB054 for treating Parkinson's disease and movement disorders; BIIB067, BIIB078, and BIIB110 to treat neuromuscular disorders; BIIB093, TMS-007, and Natalizumab to treat acute neurology; BIIB104 for treating neurocognitive disorders; BIIB074 and BIIB095 for pain; and Dapirolzumab pegol, BG00011, and BIIB059 for treating other diseases, which are under various stages of development.
The company offers products through its sales force and marketing groups. Biogen Inc. has collaboration agreements with Genentech, Inc., Eisai Co., Ltd., Alkermes Pharma Ireland Limited, Bristol-Myers Squibb Company, Acorda Therapeutics, Inc., AbbVie Inc., C4 Therapeutics, University of Pennsylvania, Applied Genetic Technologies Corporation, and others. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
-
IndustryBiotechnology
-
No. of Employees7,800
-
Website
-
Jobs Posted445
